精准影像医学专题 |
|
|
|
|
胰腺癌的影像学精准诊断与评估 |
潘瑶, 陈洁瑜, 余日胜 |
浙江大学医学院附属第二医院放射科, 浙江 杭州 310009 |
|
Accurate imaging diagnosis and evaluation of pancreatic cancer |
PAN Yao, CHEN Jieyu, YU Risheng |
Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China |
[1] |
CONROY T, BACHET J B, AYAV A, et al. Current standards and new innovative approaches for treatment of pancreatic cancer[J]. Eur J Cancer,2016,57:10-22.
|
[2] |
HERREROS-VILLANUEVA M, GIRONELLA M, CASTELLS A, et al. Molecular markers in pancreatic cancer diagnosis[J]. Clin Chim Acta,2013,418(1):22-29.
|
[3] |
KITAJIMA K, MURAKAMI K, YAMASAKI E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer:comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT[J]. Mol Imaging Biol,2010,12(4):452-459.
|
[4] |
FREENY P C, MARKS W M, RYAN J A, et al. Pancreatic ductal adenocarcinoma:diagnosis and staging with dynamic CT[J]. Radiology,1988,166(1 Pt 1):125-133.
|
[5] |
SCHIMA W, BA-SSALAMAH A, KOLBLINGER C, et al. Pancreatic adenocarcinoma[J]. Eur Radiol,2007,17(3):638-649.
|
[6] |
JUNG K W, KIM M H, LEE T Y, et al. Clinicopathological aspects of 542 cases of pancreatic cancer:a special emphasis on small pancreatic cancer[J]. J Korean Med Sci,2007,22 Suppl:S79-S85.
|
[7] |
PROKESCH R W, CHOW L C, BEAULIEU C F, et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT:secondary signs[J]. Radiology,2002,224(3):764-768.
|
[8] |
YOON S H, LEE J M, CHO J Y, et al. Small (≤ 20 mm) pancreatic adenocarcinomas:analysis of enhancement patterns and secondary signs with multiphasic multidetector CT[J]. Radiology,2011,259(2):442-452.
|
[9] |
BALCI N C, SEMELKA R C. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma[J]. Eur J Radiol,2001,38(2):105-112.
|
[10] |
PARK M J, KIM Y K, CHOI S Y, et al. Preoperative detection of small pancreatic carcinoma:value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level[J]. Radiology,2014,273(2):433-443.
|
[11] |
BOUJAOUDE J. Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma[J]. World J Gastroenterol,2007,13(27):3662-3666.
|
[12] |
SUGIYAMA Y, FUJINAGA Y, KADOYA M, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer[J]. Jpn J Radiol,2012,30(4):296-309.
|
[13] |
ICHIKAWA T, SOU H, ARAKI T, et al. Duct-penetrating sign at MRCP:usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas[J]. Radiology,2001,221(1):107-116.
|
[14] |
KIM H J, BYUN J H, PARK S H, et al. Focal fatty replacement of the pancreas:usefulness of chemical shift MRI[J]. AJR Am J Roentgenol,2007,188(2):429-432.
|
[15] |
ISSEROW J A, SIEGELMAN E S, MAMMONE J. Focal fatty infiltration of the pancreas:MR characterization with chemical shift imaging[J]. AJR Am J Roentgenol,1999,173(5):1263-1265.
|
[16] |
TO'O K J, RAMAN S S, YU N C, et al. Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia[J]. Radiographics,2005,25(4):949-965.
|
[17] |
KIMURA Y, KIKUYAMA M, KODAMA Y. Acute pancreatitis as a possible indicator of pancreatic cancer:the importance of mass detection[J]. Intern Med,2015,54(17):2109-2114.
|
[18] |
MENG Z, ZHANG X, ZHENG Q, et al. Acute pancreatitis as an early indicator of pancreatic head carcinoma[J]. Hepatogastroenterology,2014,61(133):1201-1206.
|
[19] |
SIEGEL R, MA J, ZOU Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(1):9-29.
|
[20] |
LOYER E M, DAVID C L, DUBROW R A, et al. Vascular involvement in pancreatic adenocarcinoma:reassessment by thin-section CT[J]. Abdom Imaging,1996,21(3):202-206.
|
[21] |
LU D S, REBER H A, KRASNY R M, et al. Local staging of pancreatic cancer:criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT[J]. AJR Am J Roentgenol,1997,168(6):1439-1443.
|
[22] |
LI H, ZENG M S, ZHOU K R, et al. Pancreatic adenocarcinoma:the different CT criteria for peripancreatic major arterial and venous invasion[J]. J Comput Assist Tomogr,2005,29(2):170-175.
|
[23] |
KLAUSS M, MOHR A, VON TENGG-KOBLIGK H, et al. A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography[J]. Pancreatology,2008,8(2):204-210.
|
[24] |
MARINELLI T, FILIPPONE A, TAVANO F, et al. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer:influence on borderline resectable[J]. Radiol Med,2014,119(5):334-342.
|
[25] |
BIPAT S, PHOA S S, VAN DELDEN O M, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma:a meta-analysis[J]. J Comput Assist Tomogr,2005,29(4):438-445.
|
[26] |
FERRONE C R, MARCHEGIANI G, HONG T S, et al. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer[J]. Ann Surg,2015,261(1):12-17.
|
[27] |
KATZ M H, FLEMING J B, BHOSALE P, et al. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators[J]. Cancer,2012,118(23):5749-5756.
|
[28] |
CASSINOTTO C, MOURIES A, LAFOURCADE J P, et al. Locally advanced pancreatic adenocarcinoma:reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy[J]. Radiology,2014,273(1):108-116.
|
[29] |
CASSINOTTO C, CORTADE J, BELLEANNEE G, et al. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment[J]. Eur J Radiol,2013,82(4):589-593.
|
[30] |
THOMASSET S C, LOBO D N. Pancreatic cancer[J]. Surgery(Oxford),2010,28(5):198-204.
|
[31] |
IMAI H, DOI R, KANAZAWA H, et al. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer[J]. Int J Clin Oncol,2010,15(3):294-300.
|
[32] |
GOLDER W A. Lymph node diagnosis in oncologic imaging:a dilemma still waiting to be solved[J]. Onkologie,2004,27(2):194-199.
|
[33] |
I·NAL A, KOS F T, ALGIN E, et al. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer:a retrospective analysis of a multicentre study (anatolian society of Medical Oncology)[J]. Contemp Oncol (Pozn),2015,19(2):125-129.
|
[34] |
BRUEGEL M, HOLZAPFEL K, GAA J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique[J]. Eur Radiol,2008,18(3):477-485.
|
[35] |
MOTOSUGI U I T, MORISAKA H, SOU H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging_comparison with contrast-enhanced multi-detector row CT[J]. Radiology,2011,260:446-453.
|
[36] |
LEE K H, LEE J M, PARK J H, et al. MR imaging in patients with suspected liver metastases:value of liver-specific contrast agent gadoxetic acid[J]. Korean J Radiol,2013,14(6):894-904.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|